The purpose of this study was to compare a selective A 2A adenosine receptor agonist (regadenoson) with adenosine in clinically relevant canine models with regard to effects on hemodynamics 
99m
Tc-sestaMIBI biodistribution and kinetics. The arterial blood clearance half-time was significantly faster for Tc-MIBI) , are used interchangeably for the detection of coronary artery disease. However, there are substantial differences in myocardial uptake, clearance kinetics, and biodistribution among the 99m Tc-labeled tracers and 201 Tl (1, 2) , which should be considered in myocardial perfusion imaging (MPI).
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The accuracy of MPI is dependent on the biodistribution of tracers in organs adjacent to the heart (i.e., lungs, liver) and affects the optimal timing of MPI (3) . Patients with a critical coronary stenosis who are unable to exercise are injected during pharmacological vasodilator stress to mimic alterations in coronary flow associated with exercise stress. The level or type of stress can affect the biodistribution (4) (5) (6) (7) (8) . The biodistribution of 99m Tc-MIBI is altered by exercise or pharmacological stress, suggesting that the kinetics also are influenced (3) . The uptake of 99m Tc-MIBI plateaus at high flows during adenosine vasodilator stress, potentially underestimating myocardial perfusion defect size (9) .
Adenosine used for stress MPI causes systemic vascular and hemodynamic side effects, possibly altering the biodistribution of radiotracers (9) . Most adverse effects can be attributed to A 1 , A 2B , and A 3 adenosine receptor stimulation (10) . Selective A 2A adenosine receptor agonists may reduce unwanted effects but may alter radiotracer kinetics. Regadenoson (CVT-3146, CV Therapeutics, Inc., a subsidiary of Gilead, Foster City, California), an A 2A agonist, is a potent vasodilator with a short duration of action and minimal hemodynamic effects (10, 11) . Recent clinical trials (12-16) have established regadenoson as a vasodilator for MPI.
Studies in conscious dogs and humans demonstrated that the dose and rate of regadenoson administration affects hemodynamics (11) and coronary flow (10, 17, 18) . Differential effects of regadenoson on renal and splanchnic flow may affect the biodistribution and clearance of radiotracers, having an impact on the efficacy of the vasodilator MPI.
Regadenoson duration of action and differential effects on flow (coronary and systemic) compared with adenosine may result in favorable tracer kinetics for MPI . To determine whether regadenoson results in  favorable conditions for vasodilator MPI, we evaluated   the uptake, biodistribution, and clearance of   201   Tl and   99m Tc-MIBI during vasodilation with regadenoson and adenosine in chronic, closed-chest canine models. To establish the linearity of radiotracer uptake during regadenoson stress, we used acute open-chest canine models with a critical stenosis.
M E T H O D S
Surgical preparation. Fasting adult mongrel dogs (23 Ϯ 0.9 kg) were anesthetized with intravenous sodium thiamylal (20 mg/kg). Animals were intubated and ventilated with a mixture of halothane (0.5% to 1.5%), nitrous oxide and oxygen (N 2 O:O 2 ϭ 3:1). An electrocardiogram (ECG) lead was used for heart rate (HR) and rhythm monitoring. The protocol was approved by Yale Institutional Animal Care and Use Committee in compliance with guiding principles of the American Physiologic Society on research animal use.
CHRONIC MODEL. Venous access was established for administration of radiotracer and regadenoson or adenosine. A femoral artery was cannulated for blood sampling and hemodynamic monitoring. To determine radiotracer kinetics and biodistribution, sequential imaging was performed in closed-chest (n ϭ 7) dogs under light anesthesia and physiological conditions with monitoring.
ACUTE MODEL.
To determine the effects of regadenoson on coronary flow and myocardial radiotracer uptake, an open-chest canine preparation (n ϭ 7) with a critical stenosis was used. A left lateral thoracotomy was performed and the heart suspended in a pericardial cradle. The proximal left anterior descending (LAD) and circumflex (LCX) arteries were dissected for placement of flow probes (Transonics Systems Inc., Ithaca, New York). A proximal critical LCX stenosis was created by the use of a hydraulic occluder and adjusted to blunt reactive hyperemia to a transient 10-s total coronary occlusion without impairing resting flow. Central temperature, HR, aortic pressure (AoP), and coronary flows were recorded. 
sessions. During the first session (Fig. 1A) , each dog received an intravenous injection of regadenoson (2.5 g/kg) over 30 s and then 201 Tl (55.5 Ϯ 7.4 MBq) 10 s later. Dynamic planar imaging (DPI; 15 min) followed the injection, along with timed arterial blood sampling for determination of radiotracer clearance kinetics by use of a roller-pump (20 samples at 15 s/sample, then 10 samples at 30 s/sample). Blood (0.5 ml) was collected, weighed, and counted in a gammawell-counter. Two hours later, the same regadenoson vasodilator stress protocol was repeated with injection of 99m Tc-MIBI (843.6 Ϯ 148 MBq). For the second session (Fig. 1B) , the dogs received an intravenous infusion of adenosine at a rate of 280 g/kg/min over 4.5 min. An injection of 201 Tl (59.2 Ϯ 3.7 MBq) was given 1.5 min into the adenosine infusion. Then DPI and blood withdrawals, with use of the same protocol as with regadenoson, followed the injection. Two hours later, the adenosine stress protocol was repeated but with injection of Tc-MIBI (873.2 Ϯ 166.5 MBq), and radiolabeled microspheres were injected simultaneously 10 s after the regadenoson bolus. To minimize redistribution, dogs were euthanized 15 min after tracer injection. Regional myocardial flow was measured at rest and stress with radiolabeled microspheres by the use of established methods (2) . Hearts were excised and cast with dental molding material (Alginate, Type I, fast-set, Quala Dental Products, ADC Milford, Delaware) for ex vivo single-photon emission computed tomography (SPECT) imaging, avoiding most of the confounding effects of attenuation and scatter. Hearts were sliced (5 mm), and each slice was divided into 8 radial pies. Segments underwent gamma-well-counting for the determination of tracer activity and microsphere flow. Hemodynamics. Electrocardiogram, AoP, and coronary flows were recorded 30 s before and after infusion of the vasodilator (Sonolab, Sonometrics Inc., Ontario, Canada). R-waves were used to segment the signals into individual cardiac cycles. Heart rate, systolic and diastolic AoP, and peak LAD and LCX flow were determined every 10 s. Tl ϭ thallium-201. Tc-MIBI (140 Ϯ 7.5% keV). Regions-of-interest were drawn over blood pool, myocardium, liver, lung, and kidney. Timeactivity curves were generated for each organ, and activity was expressed as percent-injected dose/pixel (%ID/pixel) by the use of an external point source Heart rate and systolic and diastolic AoP are shown for select time points after the stressor infusion. Shown are the peak alteration from baseline, the average change during the 2 min after radiotracer injection, and the value at 10 min after infusion of the stressor. There was no difference in the hemodynamic effects between groups. *p Ͻ 0.05 versus baseline. †p Ͻ 0.05 versus peak values. AoP ϭ aortic pressure; 99m Tc ϭ technetium-99m;
201
Tl ϭ thallium-201.
of known activity. The myocardium-to-liver activity and myocardium-to-lung ratios, at 15 Sc: 811 to 1,160 keV). Samples were recounted 1 week after radiotracer injection to determine microsphere flow. Myocardial flow was calculated by the use of previously published methods, with correction for radiotracer decay, spill-up, and spill-down (2). Regional flow was expressed in ml/min/g, as well as a percent nonischemic and ischemic. Tc-MIBI SPECT imaging was performed by use of the same dual-head rotational gammacamera, collimators, and energy windows applied for in vivo SPECT imaging. Images were acquired by the use of a 360°circular-orbit, in a step-andshoot fashion (64 ϫ 64 matrix; 5-mm slice thickness). No attenuation or scatter correction was required. Images were reconstructed by the use of filtered back-projection with ramp-filters. A 3-dimensional low-pass filter (Butterworth, order-4 and cutoff 0.35) was applied to post-reconstruction transverse SPECT slices, and images were reoriented into cardiac-specific axes.
The Yale-CQ-algorithm was used to quantify the SPECT images (19, 20) . Circumferential count profiles were generated for a series of left ventricular (LV) short-axis images. Three anatomic slices were divided into 128 radial sectors. Defects were defined as counts Ͻ80% of the maximum. tracer between the regadenoson-and adenosinetreated animals were assessed using a one-way analysis of variance. For conditions that demonstrated a significant main effect, post-hoc analyses were performed with either a t test (comparison between 2 populations) or a z test (comparison with %baseline).
R E S U L T S
Chronic studies. HEMODYNAMICS. A 30-s bolus of regadenoson and a 4.5-min infusion of adenosine produced similar hemodynamic effects (p ϭ NS) ( Table 1) . Peak HR significantly increased (p Ͻ 0.05), and peak systolic and diastolic AoP significantly decreased (p Ͻ 0.05) relative to baseline values. These parameters were significantly (p Ͻ 0.05) different than baseline 2 min after injection of the radiotracers. These values tended to return to baseline within 10 min (Fig. 2) . The peak effect of regadenoson occurs ϳ30 s after the bolus, whereas the peak effect of adenosine occurs 1.5 to 2 min after beginning the infusion, corresponding to radiotracer injection. The duration of the peak hemodynamic effect was shorter for regadenoson than for adenosine, although sufficient to create differential uptake of 201 Tl and (Figs. 3D to 3J) . Acute studies. HEMODYNAMICS. In the acute studies (n ϭ 7), the 30-s bolus of regadenoson caused a nearly significant increase in HR (p Ͻ 0.08) and a decrease (p Ͻ 0.05) in both systolic and diastolic AoP during the 2-min post-radiotracer injection, similar to the chronic studies. The pressures remained mildly reduced (ϳ10 mm Hg; p Ͻ 0.05) at 10 min after regadenoson administration. The flow in the stenotic LCX increased on average 6.7% (p Ͻ 0.05) over baseline, which is consistent with ablation of reactive hyperemia. In the LAD, however, the flow significantly increased (2.5-to 3-fold baseline; p Ͻ 0.001) during the 2 min after radiotracer injection. The LAD flow returned to baseline values at 10 min after regadenoson infusion (Fig. 4) .
MYOCARDIAL MICROSPHERE BLOOD FLOW. Transmural myocardial microsphere blood flow (Fig. 5) was similar between IS (0.86 Ϯ 0.24 ml/min/g) and NI (0.89 Ϯ 0.26 ml/min/g) territories at baseline. Regadenoson caused ϳ3.3-fold increase in myocardial blood flow (MBF) in the NI territory (2.98 Ϯ 0.98 ml/min/g; p Ͻ 0.05), whereas MBF in the ischemic territory was unchanged (0.95 Ϯ 0.23 ml/min/g, p ϭ NS). 
Figure 5. Transmural Absolute Myocardial Blood Flow
Average microsphere flows for ischemic and nonischemic regions at rest and during vasodilator stress. The blood flows are comparable at rest in both regions. Flows during regadenoson vasodilator stress increased 3-fold in the nonischemic region but remained unchanged in the ischemic region with a critical stenosis.
spatial variation of radiotracer uptake and myocardial microsphere flow is shown for a representative myocardial short-axis slice (Fig. 6A) . Relative 201 Tl activity approximated the flow deficit within the ischemic region better than 99m Tc-MIBI activity. Figure 6B shows the relationship between absolute myocardial flow and relative 201 Tl and 99m
Tc-MIBI retention for all segments of 1 dog. There was a linear relationship between relative myocardial 201 Tl activity and microsphere flow, even at the high flows achieved with regadenoson. However, there was considerable "roll-off" of 99m Tc-MIBI at flows ϳ1.5 times above resting flow (Fig. 6B) . The myocardial IS/NI ratio of both 201 Tl (0.53 Ϯ 0.02) and 99m Tc-MIBI (0.69 Ϯ 0.03) significantly underestimated (p Ͻ 0.001) the true flow deficit (0.34 Ϯ 0.02). However, the underestimation associated with 201 Tl activity was significantly (p Ͻ 0.001) less than that observed for 99m Tc-MIBI (Fig. 6C) .
EX VIVO SPECT QUANTIFICATION. The differences in relative regional 201 Tl and 99m Tc-MIBI uptake within the stenotic territory during regadenoson stress, demonstrated by gamma-well-counting, could also be visualized on ex vivo SPECT imaging, under conditions of minimal attenuation and scatter. Ex vivo images clearly showed the perfusion heterogeneity created using regadenoson in the presence of a critical stenosis (Fig. 7A) . However, the perfusion defect appears larger and more noticeable with 201 Tl compared with 99m Tc-MIBI, despite the lower count density. The integrated perfusion defect score was significantly Tc-MIBI (17 Ϯ 1.7 %LV) (Fig. 7B ).
D I S C U S S I O N
The current study compared the effects of regadenoson and adenosine on systemic hemodynamics, radiotracer biodistribution, and clearance kinetics in clinically relevant canine models to define the optimal approach for MPI by the use of vasodilator stress. A regadenoson bolus (2.5 g/kg) produced systemic hemodynamic effects similar to a 4.5-min adenosine infusion. Regadenoson created a 2.5-to 3-fold augmentation in microspheres flow. The HR, AoP, and coronary flow remained altered during the critical 2-min post-radiotracer injection. These effects on flow were comparable to those observed by Lieu et al. (18) in human studies, in which they used a Doppler flow wire measuring the coronary flow velocity in response to a 400-g or 500-g bolus of regadenoson. These doses were greater than what was administered to the dogs in the current study after body mass correction.
Although regadenoson and adenosine are known to have differential effects on renal and splanchnic flow (10) Tc-MIBI MPI during adenosine stress (9) and other selective A 2A adenosine agonists (21) . We observed the expected plateau of radiotracer uptake at higher flows, which has been attributed to a diffusion limitation of radiotracer uptake. In the case of 201 Tl, some of the flow underestimation may be attributed to differential washout of 201 Tl from the normal and ischemic regions, since the radiotracer distribution was evaluated at 15 min after radiotracer injection. Therefore, there may have been a slight component of Tc-MIBI uptake relative to microsphere flow in the presence of 2 levels of stenosis. Their creation of a "critical stenosis" was designed to ablate reactive hyperemia, similar to our acute studies. The microsphere flows in both studies demonstrated no increase in flow in the stenotic territory and ϳ3.5-fold flow increase in the remote territory in response to vasodilator stress. Glover et al. Tc-Tetrofosmin, although the chi-squares for both the adenosine-regadenoson and adenosineadenosine comparisons were only 0.63 or 0.64, respectively, suggesting only a fair concordance (14) . On the basis of our experimental findings, 201 Tl may offer a clinical advantage over the 99m Tclabeled perfusion agents and improve test reproducibility for determination of the extent of ischemia. Importantly, the current finding regarding the biodistribution and ex vivo SPECT imaging would predict that there should be no significant clini-cal difference between regadenoson and adenosine for MPI.
Although this pre-clinical study provides important insight regarding regadenoson and adenosine stress MPI, these studies were performed during anesthesia, which could produce confounding effects on systemic hemodynamics. In clinical studies (13, 14) , the hemodynamic changes associated with regadenoson were less and shorter-lasting than those observed in our study. Our study was specifically performed with the use of the volatile anesthetic halothane. Because Hickey et al. (22) found that there was no significant change in coronary flow reserve between conscious and halothane-anesthetized canines.
In addition, to minimize any potential adverse effect, the chronic studies were performed with the use of a closed-chest preparation that required very light anesthesia with halothane and nitrous oxide. Although halothane is a mild cardiac depressant, the effects are dose dependent (23, 24) . Therefore, the light plane of anesthesia used should have had little effect on cardiac output and the biodistribution of the radiotracers. Our hemodynamic results on anesthetized dogs closely matched the result from previous studies on conscious dogs (11) and were within physiological ranges throughout the study protocol. Glover et al. (9) used sodium pentobarbital anesthesia in their study and showed very similar hemodynamic responses to adenosine and similar kinetic behavior of 201 Tl and 99m Tc-MIBI during adenosine stress (9) .
Our anesthetized preparation offers advantages over clinical studies or conscious preparations, enabling serial imaging without risk of any subject movement, which is a significant confounder in clinical studies with repeated imaging. The changes in flow that we observed in our experimental model during vasodilator stress are concordant with a clinical study (25) in which the authors used rest and adenosine oxygen-15 water positron emission tomographic imaging in control subjects. Coronary vasodilator reserve (3.16 Ϯ 1.4) in control patients during adenosine stress was nearly identical to the ϳ3.3-fold increase we obtained in the NI territory in response to regadenoson vasodilator stress. Tc-MIBI during regadenoson were similar to adenosine vasodilation. Ex vivo perfusion images under the most ideal conditions permitted detection of a critical stenosis, although 201 Tl offered significant advantages over 99m Tc-MIBI for perfusion imaging during regadenoson vasodilator stress.
